Literature DB >> 26617854

Ki-67 and caspase expression in breast carcinoma: does variance in locational sampling exist?

Filinte Deniz1, Kaymakci Dilek1, Mollamemisoglu Hande1, Ugurlu M Umit1, Kaya Handan1.   

Abstract

Ki-67 and caspase indices are two very important prognostic variables for breast cancer. The aim of this study was to compare the immunoexpressions of these two prognostic variables at the center, the periphery of the tumor in comparison with each other, and additional parameters in 53 breast cancer specimens. It has been shown that the increase of caspase immunoexpression either at the periphery or the center of the tumor correlated with the increase of Ki-67 immunoexpression at the same areas. There was no statistically significant difference between caspase and Ki-67 immunoexpression at the center or the periphery of the tumor. No statistically significant correlation was found between immunoexpressions of caspase and Ki-67 with the tumor grade, stage, lymph node metastasis, lymphovascular or perineural invasion. The two very important prognostic variables of breast cancer (caspase and Ki-67) were evenly distributed in the center and the periphery of the tumor. It is evident that there is no need for a specific locational sampling when these two variables are considered. In accordance with this information, the differences in sampling due to observer diversity may be prevented.

Entities:  

Keywords:  Ki-67; breast cancer; caspase; immunohistochemistry

Mesh:

Substances:

Year:  2015        PMID: 26617854      PMCID: PMC4637670     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  33 in total

Review 1.  Mechanisms of caspase activation.

Authors:  Kelly M Boatright; Guy S Salvesen
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

2.  Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis.

Authors:  B Chevallier; F Heintzmann; V Mosseri; J P Dauce; P Bastit; Y Graic; P Brunelle; J P Basuyau; M Comoz; B Asselain
Journal:  Cancer       Date:  1988-12-15       Impact factor: 6.860

Review 3.  Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.

Authors:  Frédérique Spyratos; Magali Ferrero-Poüs; Martine Trassard; Kamel Hacène; Edelmira Phillips; Michèle Tubiana-Hulin; Viviane Le Doussal
Journal:  Cancer       Date:  2002-04-15       Impact factor: 6.860

4.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

5.  Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma.

Authors:  J Chang; M Ormerod; T J Powles; D C Allred; S E Ashley; M Dowsett
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

6.  Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?

Authors:  Helen Trihia; Susan Murray; Karen Price; Richard D Gelber; Rastko Golouh; Aron Goldhirsch; Alan S Coates; John Collins; Monica Castiglione-Gertsch; Barry A Gusterson
Journal:  Cancer       Date:  2003-03-01       Impact factor: 6.860

7.  Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy.

Authors:  Thomas A Buchholz; Darren W Davis; David J McConkey; W Fraser Symmans; Vicente Valero; Anuja Jhingran; Susan L Tucker; Lajos Pusztai; Massimo Cristofanilli; Francisco J Esteva; Gabriel N Hortobagyi; Aysegul A Sahin
Journal:  Cancer J       Date:  2003 Jan-Feb       Impact factor: 3.360

8.  Ki-67 immunostaining in human breast tumors and its relationship to prognosis.

Authors:  H O Wintzer; I Zipfel; J Schulte-Mönting; U Hellerich; S von Kleist
Journal:  Cancer       Date:  1991-01-15       Impact factor: 6.860

Review 9.  Immunohistochemical markers as predictive tools for breast cancer.

Authors:  R A Walker
Journal:  J Clin Pathol       Date:  2007-11-23       Impact factor: 3.411

10.  Management and survival of female breast cancer: results of a national survey by the American College of Surgeons.

Authors:  T Nemoto; J Vana; R N Bedwani; H W Baker; F H McGregor; G P Murphy
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

View more
  2 in total

1.  Clinical correlates of circulating cell-free DNA tumor fraction.

Authors:  Joerg Bredno; Jafi Lipson; Oliver Venn; Alexander M Aravanis; Arash Jamshidi
Journal:  PLoS One       Date:  2021-08-25       Impact factor: 3.240

2.  Correlation of magnetic resonance imaging quantitative parameters and apparent diffusion coefficient value with pathological breast cancer.

Authors:  Zhe Wang; Guan-Ying Ren; Qian Yin; Qian Wang
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.